Evidence map›Paper›PMID 41493411›Full record

ArticleJACC. Heart failure2026

Artificial Intelligence to Extract Structured Details From Unstructured Medical Records in a Global Heart Failure Trial.

Samarra Badrouchi, Pablo M Marti-Castellote, Alberto Foà, Brian L Claggett, Akshay S Desai, Dongchu Xu, Jennifer E Ho, Patrick Ellinor, Pardeep S Jhund, Martina M McGrath and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Samarra BadrouchiDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Department of Nephrology, Charles Nicolle University Hospital, Faculty of Medicine of Tunis-University of Tunis El Manar, Tunis, Tunisia.
Pablo M Marti-CastelloteDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Alberto FoàDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Heart Failure and Transplant Unit-IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Brian L ClaggettDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Akshay S DesaiDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Dongchu XuDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jennifer E HoCardiovascular Disease Initiative, Broad Institute of Harvard University and the Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; CardioVascular Institute and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Patrick EllinorCardioVascular Institute and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pardeep S JhundBritish Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Martina M McGrathNephrology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Finnian R McCauslandNephrology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
John J V McMurrayBritish Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Scott D SolomonDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: ssolomon@bwh.harvard.edu.
Jonathan W CunninghamDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Cardiovascular Disease Initiative, Broad Institute of Harvard University and the Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Funding

Effect of Neprilysin Inhibition on Myocardial Interstitial FibrosisK23HL168163 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Jonathan Woo Cunningham · 2024 to 2026
$586k
NHLBI NIH HHS K23 HL168163
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

artificial intelligenceclinical trialsheart failurelarge language models

Identifiers

PMID41493411
PMCPMC12949679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.